Dragon Pharma CY3 – Triple-Action Metabolic Blend
✔ Triple-mechanism thermogenic synergy ✔ Beta-2 agonist + thyroid hormone + alpha-2 antagonist ✔ USA & International shipping
Dragon Pharma CY3 is a specialized oral formulation combining three synergistic metabolic agents: Clenbuterol HCl (37 mcg), T3 Liothyronine (25 mcg), and Yohimbine HCl (5.4 mg). This triple-action blend is designed for research into thermogenesis, lipolysis, and metabolic rate modulation. Each tablet delivers this precise ratio of actives for convenient research administration.
CY3 combines three distinct mechanisms for comprehensive metabolic research. Clenbuterol is a selective beta-2 adrenergic agonist that stimulates thermogenesis and lipolysis through cAMP-dependent pathways. T3 Liothyronine is the active thyroid hormone that regulates basal metabolic rate and enhances sensitivity to catecholamines. Yohimbine is an alpha-2 adrenergic antagonist that blocks negative feedback inhibition of norepinephrine on fat cells. Together, these compounds provide multi-pathway activation of metabolic processes for advanced research. For researchers investigating synergistic thermogenic mechanisms, thyroid and adrenergic pathway interactions, or combination strategies for metabolic research, Dragon Pharma CY3 delivers a ready-to-use blended formulation. When researchers seek legit CY3 for advanced metabolic studies, Dragon Pharma provides batch-traceable, precision-dosed tablets.
Why Athletes & Bodybuilders Are Researching CY3 Blend
Within performance research communities, the CY3 blend is studied for its triple-mechanism approach to metabolic rate enhancement. Research focuses on the synergistic effects of beta-2 agonism (Clenbuterol), thyroid hormone supplementation (T3), and alpha-2 antagonism (Yohimbine) on thermogenesis, lipolysis, and overall metabolic rate in animal models.
What Makes Dragon Pharma CY3 Different?
- ✔ Triple mechanism synergy – Beta-2 agonist + thyroid hormone + alpha-2 antagonist for comprehensive metabolic research.
- ✔ Precision ratio formulation – Optimized 37 mcg / 25 mcg / 5.4 mg blend for synergistic research applications.
- ✔ Multi-pathway activation – Targets thermogenesis, basal metabolic rate, and lipolytic signaling simultaneously.
- ✔ Single-tablet convenience – Pre-blended formulation eliminates need for separate compound handling.
Research Use Only
Important: This product is for laboratory research purposes only. Not for human or veterinary use. Lab test reports are coming soon for this batch – we commit to full transparency.
For researchers requiring a comprehensive metabolic research tool with triple adrenergic and thyroid pathway activation, legit CY3 from Dragon Pharma delivers a professionally formulated, lab-verified blend.
Product Specifications
Compound Names
Clenbuterol HCl + T3 Liothyronine + Yohimbine HCl
Research Focus
Thermogenesis, lipolysis, metabolic rate modulation, adrenergic signaling, thyroid hormone pathways
Mechanisms
Clenbuterol: Beta-2 adrenergic agonist / T3: Thyroid hormone receptor agonist / Yohimbine: Alpha-2 adrenergic antagonist
Form
Oral tablet – triple active blend
Strength
Clenbuterol: 37 mcg / T3: 25 mcg / Yohimbine: 5.4 mg per tablet
Package Size
100 tablets per sachet
Purity
≥99% (lab test coming soon)
Duration (Research)
Clenbuterol: 24-48 hrs / T3: 24-48 hrs / Yohimbine: 6-10 hrs – research dependent
Storage
Controlled room temperature (15–25°C) – keep away from moisture
Availability
USA Domestic & International
🔬 Lab test report coming soon. Dragon Pharma commits to publishing third-party HPLC test results for all research compounds. Check back for the complete COA.
Dosage & Research Guidelines
For laboratory research use only. CY3 is a triple-action metabolic blend for research purposes. Proper dosing accuracy and careful consideration of potency are essential. Not for human or veterinary use.
Research Dosing Guidelines
CY3 combines three active compounds with distinct mechanisms and durations. Typical research protocols utilize once daily administration due to the extended half-lives of Clenbuterol and T3. Due to the potency of this blend, careful dose selection is essential.
- ✔ Triple mechanism for comprehensive metabolic research – Beta-2 agonism + thyroid hormone + alpha-2 antagonism
- ✔ One 100-tablet sachet provides 3,700 mcg Clenbuterol + 2,500 mcg T3 + 540 mg Yohimbine
- ✔ Research cycles typically run 4-6 weeks for metabolic studies
- ✔ Once daily administration due to extended half-lives of Clenbuterol and T3
Dosing Guide
Using CY3 tablets (37 mcg Clen / 25 mcg T3 / 5.4 mg Yohimbine per tablet):
- ✔ 0.25 tablet = 9.25 mcg Clen + 6.25 mcg T3 + 1.35 mg Yohimbine
- ✔ 0.5 tablet = 18.5 mcg Clen + 12.5 mcg T3 + 2.7 mg Yohimbine
- ✔ 0.75 tablet = 27.75 mcg Clen + 18.75 mcg T3 + 4.05 mg Yohimbine
- ✔ 1 tablet = 37 mcg Clen + 25 mcg T3 + 5.4 mg Yohimbine
- ✔ 1.5 tablets = 55.5 mcg Clen + 37.5 mcg T3 + 8.1 mg Yohimbine
- ✔ 2 tablets = 74 mcg Clen + 50 mcg T3 + 10.8 mg Yohimbine
- ✔ Administer orally according to research protocol – careful dose selection due to potency
How Researchers Are Using CY3 Blend
CY3 is valued in research for its triple-mechanism approach to metabolic enhancement, combining beta-2 agonism with thyroid hormone and alpha-2 antagonism in a single formulation. Researchers study its effects on thermogenesis, lipolysis, and metabolic rate.
Popular research stacks include:
- ✔ CY3 + GW501516 – for combined metabolic and PPARδ research. View GW501516 →
- ✔ CY3 + MK 677 – for combined metabolic and GH secretagogue research. View MK 677 →
- ✔ CY3 + Albuterol – for comparative beta-2 agonist research. View Salbutamol →
Research Protocol Example (4 Weeks)
- ✔ Weeks 1-4: CY3 – 0.25-1 tablet daily administered via oral route, with dose titration as per research protocol
- ✔ Weeks 1-4: GW501516 – 10-20 mg daily (optional for metabolic pathway studies)
- ✔ Washout period: 1-2 weeks for compound clearance
Important Considerations
- 🔬 Triple mechanism: Clenbuterol (beta-2 agonist) stimulates thermogenesis; T3 increases basal metabolic rate; Yohimbine (alpha-2 antagonist) blocks lipolysis inhibition – synergistic metabolic activation
- 💧 All three compounds are orally bioavailable with extended durations (Clenbuterol and T3 24-48 hrs)
- ⚠️ Combined potency requires careful dose selection – start with lower doses in research protocols
- 📦 Once daily administration recommended due to extended half-lives of Clenbuterol and T3
- 📦 Always source Dragon Pharma CY3 from verified suppliers with batch traceability
Research Note: CY3 provides complementary metabolic mechanisms: Clenbuterol activates beta-2 receptors to stimulate thermogenesis, T3 increases basal metabolic rate and enhances catecholamine sensitivity, and Yohimbine blocks alpha-2 receptors that inhibit norepinephrine-mediated fat release. This triple mechanism makes CY3 a comprehensive tool for metabolic research. Always follow institutional laboratory safety guidelines when handling research compounds.
Lab Verification – Third-Party Testing Coming Soon
Lab Test Report in Progress
Dragon Pharma is committed to complete transparency. A third-party HPLC test is currently being processed for CY3. The full COA including measured concentration of all three actives, purity, and content uniformity will be published here as soon as it is available.
📋 Expected test parameters: Clenbuterol concentration (target 37 mcg), T3 concentration (target 25 mcg), Yohimbine concentration (target 5.4 mg), purity percentage, content uniformity confirmation.
What Will Be Tested?
- ✔ Clenbuterol concentration – HPLC assay to verify 37 mcg label claim
- ✔ T3 Liothyronine concentration – HPLC assay to verify 25 mcg label claim
- ✔ Yohimbine concentration – HPLC assay to verify 5.4 mg label claim
- ✔ Purity analysis – Detection of any impurities or degradation products
- ✔ Content uniformity – Verification of consistent dosing across tablets
Why Third-Party Testing Matters
Triple-active blends require particularly rigorous quality control to ensure accurate ratios of all three compounds. Independent laboratory verification is the only reliable method to confirm product integrity. Dragon Pharma maintains a strict policy of third-party testing for all products, and CY3 is no exception. Once the lab report is complete, it will be published here with full transparency.
For more information on adrenergic and thyroid receptor research, refer to this PubMed study on metabolic regulation.
🔬 Every batch verified. Dragon Pharma commits to publishing third-party lab results for all research compounds. Check back soon for the complete COA.
Shipping & Product Authenticity
USA Domestic
4–5 business days
International
13–15 business days
Order Processing
24–48 business hours
Tracking
Tracking number provided
Discreet Shipping & Direct Supply
All Dragon Pharma CY3 orders ship directly from authorized distribution points. Outer packaging is discreet with no mention of product contents – just a plain box with a shipping label. Sachets are sealed and tamper-evident.
What to Expect
- ✔ Orders processed within 24–48 hours after payment confirmation
- ✔ USA Domestic shipping via USPS/UPS/FedEx – tracking included
- ✔ International tracking available (update frequency varies by destination)
- ✔ Sachets shipped in protective packaging with tamper-evident seals
- ✔ Tablets shipped at ambient temperature – store properly upon arrival
How to Verify You Have Legit CY3
Counterfeit research compounds are a real problem. Here's how to confirm you are getting authentic Dragon Pharma CY3:
- ✔ QR code verification – each sachet includes a unique QR code. Scan it to verify the batch on Dragon Pharma's official database
- ✔ Scratch-off serial number – reveals a one-time use code for online verification
- ✔ Batch traceability – match the batch number on the sachet to official records
- ✔ Original sealed sachet – tamper-evident packaging with Dragon Pharma labeling
Authenticity guarantee: Every sachet of legit CY3 from Dragon Pharma includes batch-level traceability. If your product does not verify, contact us immediately for resolution.
Verified Supply Chain
⚠️ Important: Only purchase from authorized sources. Fake CY3 blends may contain incorrect compound ratios, wrong concentrations, or harmful impurities. Always verify before using in research.
For complete delivery details, tracking policy, international customs, and reshipment terms, please see our Shipping Info page.
Storage Guidelines
Store at Controlled Room Temperature
Dragon Pharma CY3 tablets require proper storage to maintain compound integrity and research validity.
Storage Recommendations
- ✔ Store at 15–25°C (59–77°F) – controlled room temperature
- ✔ Keep in original sachet packaging, away from light and moisture
- ✔ Do not refrigerate – refrigeration may introduce moisture
- ✔ Stable for up to 24 months when stored properly
- ✔ Avoid repeated temperature fluctuations
What to Avoid
- ❌ Exposure to high humidity – tablets may degrade
- ❌ Leaving at extreme temperatures (>30°C) – accelerates degradation
- ❌ Storing in bathroom or near heat sources
- ❌ Using tablets that appear discolored or show signs of moisture damage
- ❌ Opening the sachet before ready to use – keep sealed until needed
Inspection Before Use
Before using in your research, always inspect the sachet and tablets:
- ✔ Sachet should be sealed and intact – do not use if seal is broken or damaged
- ✔ Tablets should be uniform in appearance, free from discoloration or visible defects
- ✔ Check batch number and QR code for authenticity before first use
⚠️ Research note: Degraded compounds can produce unreliable research results. If you suspect your CY3 blend has been stored improperly (exposed to moisture or extreme temperatures), do not use it in critical research. Contact support for batch verification.
Keep out of reach of children and unauthorized personnel. Follow institutional laboratory safety guidelines for handling research compounds.
Frequently Asked Questions
What is CY3 and how does it work?
CY3 is a triple-action metabolic blend combining Clenbuterol (beta-2 agonist), T3 Liothyronine (thyroid hormone), and Yohimbine (alpha-2 antagonist) for synergistic research into thermogenesis and lipolysis.
Is Dragon Pharma CY3 legit?
Yes. Dragon Pharma CY3 is manufactured under strict quality standards with batch traceability and QR code verification. Lab test results are coming soon and will be published here with full transparency.
What is the typical research dose for CY3?
Typical research doses range from 0.25-1 tablet daily. Using 1 tablet: 37 mcg Clen + 25 mcg T3 + 5.4 mg Yohimbine. Due to potency, start with lower doses (0.25-0.5 tablet) and titrate as per research protocol.
What is the advantage of combining Clenbuterol, T3, and Yohimbine?
The three compounds work through distinct mechanisms: Clenbuterol stimulates thermogenesis, T3 increases basal metabolic rate and enhances catecholamine sensitivity, and Yohimbine blocks alpha-2 mediated lipolysis inhibition for synergistic metabolic activation.
Can I stack CY3 with other research compounds?
Yes. Popular stacks include
GW501516 for PPARδ metabolic research,
MK 677 for GH pathway studies, or
Salbutamol for comparative beta-2 agonist research.
How should I store CY3 tablets?
Store at controlled room temperature (15–25°C / 59–77°F). Keep in original sachet away from light and moisture. Do not refrigerate.
How long does one 100-tablet sachet last?
At 0.5 tablet daily, one sachet lasts 200 days. At 1 tablet daily, it lasts 100 days. Most metabolic research protocols require 1 sachet depending on dosing schedule.
What is the duration of action for each component?
Clenbuterol has a half-life of 24-36 hours, T3 has a half-life of approximately 24 hours, and Yohimbine has a half-life of 6-10 hours, making once-daily administration appropriate for most research protocols.
Is CY3 for human or veterinary use?
Neither. This product is a research compound for laboratory use only. It is not approved by the FDA for human or veterinary use. Dragon Pharma sells this product strictly for research purposes.
Where can I buy legit CY3 blend?
You are currently on the official product page for Dragon Pharma CY3. Order directly through our secure website to receive genuine, batch-traceable tablets with upcoming lab test results.
Still have questions? Contact our support team for research-related inquiries. For specific medical or clinical advice, consult with qualified professionals.